Breaking News Instant updates and real-time market news.

AKBA

Akebia

$7.91

0.44 (5.89%)

, KERX

Keryx

$2.93

0.17 (6.16%)

17:19
11/15/18
11/15
17:19
11/15/18
17:19

Akebia and Keryx announce chairperson for combined company

Akebia Therapeutics (AKBA), and Keryx Biopharmaceuticals (KERX) announced that Adrian Adams will serve as the Chairperson of the Akebia Board of Directors, effective upon completion of the proposed merger of Akebia and Keryx.

AKBA

Akebia

$7.91

0.44 (5.89%)

KERX

Keryx

$2.93

0.17 (6.16%)

  • 27

    Nov

  • 11

    Dec

  • 11

    Dec

AKBA Akebia
$7.91

0.44 (5.89%)

08/23/18
HCWC
08/23/18
NO CHANGE
HCWC
Keryx, Akebia merger remains on track, says H.C. Wainwright
H.C. Wainwright analyst Jason Kolbert believes the merger between Keryx Biopharmaceuticals (KERX) and Akebia Therapeutics (AKBA) remains on track. According to the Federal Trade Commission website, the status of the merger application now shows "granted," Kolbert tells investors in a research note. The analyst says that while he did not expect FTC clearance to be an issue, "it's good to see it granted." He keeps a Buy rating on Keryx with a $9 price target.
09/07/18
MSCO
09/07/18
INITIATION
Target $9
MSCO
Equal Weight
Akebia resumed with an Equal Weight at Morgan Stanley
Morgan Stanley analyst David Lebowitz resumed coverage of Akebia (AKBA) with an Equal Weight rating and $9 price target, stating that value is primarily driven by the potential of vadadustat as a treatment for anemia associated with chronic kidney disease. Vadadustat is a year behind FibroGen's (FGEN) competing HIF-inhibitor roxadustat and that lead could be an advantage if the data for the two drugs is not sufficiently differentiated, said Lebowitz.
10/22/18
MZHO
10/22/18
NO CHANGE
Target $17
MZHO
Buy
Akebia 'significantly undervalued' ahead of catalysts, says Mizuho
Mizuho analyst Difei Yang views Akebia Therapeutics as "significantly undervalued" ahead of catalysts expected in 2019 including data readouts from vadadustat and launch metrics from Auryxia. The stock is one to pay attention to in 2019 following poor performance in 2018 "despite making progress in multiple pivotal trials," Yang tells investors in a research note. She lowered her price target for the shares to $17 from $21 and keeps a Buy rating on Akebia.
11/12/18
11/12/18
DOWNGRADE

Market Perform
Raymond James downgrades Keryx to Market Perform ahead of Akebia deal closing
As previously reported, Raymond James analyst Reni Benjamin downgraded Keryx (KERX) to Market Perform from Outperform as he sees shares trading in-line with the market until the merger with Akebia (AKBA) is complete. The potential merger with Akebia is likely to go through by year-end, Benjamin contends. The merged company is likely to become "a fully-integrated renal powerhouse," the analyst added.
KERX Keryx
$2.93

0.17 (6.16%)

07/12/18
PIPR
07/12/18
NO CHANGE
Target $22
PIPR
Overweight
Piper incrementally positive on Akebia shares, ups target to $22
Piper Jaffray analyst Christopher Raymond is incrementally positive on shares of Akebia Therapeutics after new nephrologist survey data indicated that Auryxia "has not just turned a corner, but is really on quite a roll, both in terms of the drug's perception and its market share dynamics." With the stock down 4% since before last month's merger announcement with Keryx (KERX), Raymond sees a "significant opportunity" to own Akebia before the drug's near-term share gains and the "real potential of a nephrology powerhouse with both Auryxia and vadadustat, become more apparent." He raised his price target for the shares to $22 from $20 and keeps an Overweight rating on the name.
11/12/18
RAJA
11/12/18
DOWNGRADE
RAJA
Market Perform
Keryx downgraded to Market Perform from Outperform at Raymond James

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/19/18
12/19
10:17
12/19/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/19/18
12/19
10:16
12/19/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
12/19/18
12/19
10:15
12/19/18
10:15
General news
U.S. existing home sales rose 1.9% to 5.320 M in November »

U.S. existing home sales…

10:15
12/19/18
12/19
10:15
12/19/18
10:15
General news
Breaking General news story  »

Week of 12/14 EIA…

XLU

Utilities SPDR

$54.42

-0.21 (-0.38%)

10:10
12/19/18
12/19
10:10
12/19/18
10:10
Options
18.8K SPDR Utility Fund Dec 51 - 53 put spreads trade 12c »

18.8K SPDR Utility Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FND

Floor & Decor

$26.63

0.09 (0.34%)

10:06
12/19/18
12/19
10:06
12/19/18
10:06
Recommendations
Floor & Decor analyst commentary  »

Morgan Stanley says Floor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWA

BorgWarner

$35.14

0.73 (2.12%)

10:05
12/19/18
12/19
10:05
12/19/18
10:05
Hot Stocks
BorgWarner extends agreement to be Official Turbocharger Partner of INDYCAR »

BorgWarner and INDYCAR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEED

Origin Agritech

$6.37

(0.00%)

10:03
12/19/18
12/19
10:03
12/19/18
10:03
Hot Stocks
Origin Agritech announces establishment of two additional joint ventures »

Origin Agritech announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:02
12/19/18
12/19
10:02
12/19/18
10:02
General news
Existing Home Sales data reported »

November Existing Home…

APD

Air Products

$156.68

1.95 (1.26%)

10:02
12/19/18
12/19
10:02
12/19/18
10:02
Hot Stocks
Air Products to supply three nitrogen generation plants to energy project »

Air Products and N.V.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$169.62

-15.39 (-8.32%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
FedEx falls -8.4% »

FedEx is down -8.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSI

FTS International

$7.54

-0.7 (-8.50%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
FTS International falls -8.6% »

FTS International is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

UGAZ

VelocityShares 3x Long Natural Gas ETN

$73.20

-14.04 (-16.09%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -15.9% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JBL

Jabil

$24.37

2.16 (9.73%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
Jabil rises 9.8% »

Jabil is up 9.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$169.62

-15.39 (-8.32%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Options
Fedex delivers pain to pre-earnings call buyers »

Fedex delivers pain to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIVI

Civitas Solutions

$17.60

1.91 (12.17%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
Civitas Solutions rises 12.5% »

Civitas Solutions is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$84.73

11.65 (15.94%)

10:00
12/19/18
12/19
10:00
12/19/18
10:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 15.9% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$138.38

-8.39 (-5.72%)

09:55
12/19/18
12/19
09:55
12/19/18
09:55
Options
Allergan put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

GIS

General Mills

$39.15

2.45 (6.68%)

, GE

General Electric

$7.65

0.38 (5.23%)

09:55
12/19/18
12/19
09:55
12/19/18
09:55
Options
Early notable gainers among liquid option names on December 19th »

Notable gainers among…

GIS

General Mills

$39.15

2.45 (6.68%)

GE

General Electric

$7.65

0.38 (5.23%)

FCX

Freeport McMoRan

$10.73

0.13 (1.23%)

SEE

Sealed Air

$34.68

0.72 (2.12%)

CF

CF Industries

$42.94

1.17 (2.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$255.67

0.58 (0.23%)

09:51
12/19/18
12/19
09:51
12/19/18
09:51
Periodicals
White House won't tell CNBC when Trump spoke to Powell last »

CNBC's Eamon Javers…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$255.67

0.58 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:50
12/19/18
12/19
09:50
12/19/18
09:50
General news
U.S. existing home sales preview: »

U.S. existing home sales…

FDX

FedEx

$168.79

-16.22 (-8.77%)

09:47
12/19/18
12/19
09:47
12/19/18
09:47
Hot Stocks
FedEx falls -8.7% »

FedEx is down -8.7%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$72.52

-14.72 (-16.87%)

09:47
12/19/18
12/19
09:47
12/19/18
09:47
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -16.7% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSI

FTS International

$7.44

-0.8 (-9.71%)

09:47
12/19/18
12/19
09:47
12/19/18
09:47
Hot Stocks
FTS International falls -10.0% »

FTS International is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Feb

CIVI

Civitas Solutions

$17.59

1.9 (12.11%)

09:47
12/19/18
12/19
09:47
12/19/18
09:47
Hot Stocks
Civitas Solutions rises 12.3% »

Civitas Solutions is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.